Easton Pharmaceuticals, Inc. (EAPH)

[Rsarabjit]

Annual report shows 378k revs. - 145% imcrease. Great turnaround stock.

Easton Announces Filing of Its Financial Statements for the Year Ended December 31, 2018 with a Revenue Increase of 145% Over 2017 and Provides General Business UpdatePress Release | 03/18/2019

TORONTO, ON / ACCESSWIRE / March 18, 2019 / Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) Announces that it has filed its Financial Statements for the Year Ended December 31, 2018 and provides general updates on Its business initiatives.
Easton realized revenues of $378,589 USD during 2018, an increase in revenues over 145% from 2017. The Company's revenues primarily derived during the last 2 quarters from activities generated from its Georgina property, as well as from its construction contract to frame 150 new homes, through its Real Estate and Development Division. Easton's management announced last year that it would be entering into additional lucrative market segments that its directors have experience in.
The Company has created a Real Estate and Development Division, which will manage its ownership in its Georgina property, as well as its recently acquired Cobourg development property. This Division also provides construction services to builders and other clients, such as its framing contract. Easton has also created a Gaming Division, a Food and Beverage Division and a Cannabis Division. The Company is maintaining its Pharmaceutical Division, which includes a lucrative distribution agreement with BAYER, scheduled to launch in Q2. Additional consumer products are currently being negotiated and will be added to the Pharmaceutical Division. The Gaming Division is expected to complete a profitable agreement with a casino in the United States in Q2, while Easton recently announced its acquisition of a commercial bakery and food processing facility in Toronto, which is scheduled to close later this month and will mark its entry into the Food and Beverage industry. The Company's Cannabis Division is also in discussions with several Licensed Producers of Medicinal Marijuana in Canada and hopes to complete a strategic partnership shortly.
Easton has put in place the infrastructure that the Company will require to effectively and efficiently manage its operations and growth moving forward.